Recursion Pharmaceuticals: compare with another company

13 comparisons, best match first. Pick one to see it side by side.

• Recursion Pharmaceuticals vs Isomorphic LabsBoth are AI-native drug-discovery platforms — Recursion OS against Isomorphic's Drug Design Engine — named as rivals in Recursion's own 10-K.
• Recursion Pharmaceuticals vs Insilico MedicineBoth platforms screen and design drug candidates with AI/ML; Insilico's own HKEX prospectus names Recursion in its Competitive Landscape table.
• Recursion Pharmaceuticals vs Chai DiscoveryChai Discovery platform and Recursion OS both list drug discovery; both also serve buyers who need to find drug candidates faster; smaller scale (public).
• Recursion Pharmaceuticals vs CradleCradle and Recursion OS both list drug discovery; both also serve buyers who need to find drug candidates faster; Cradle's scale not recorded.
• Recursion Pharmaceuticals vs Xaira TherapeuticsRecursion OS and Xaira AI platform (X-Cell, X-Design, X-Patient) both list drug discovery; both also serve buyers who need to find drug candidates faster; Xaira Therapeutics's scale not recorded.
• Recursion Pharmaceuticals vs Origin BioOrigin Bio data engine and Axis and Recursion OS both list drug discovery; both also serve buyers who need to find drug candidates faster; Origin Bio's scale not recorded; ships platform rather than the same layer.
• Recursion Pharmaceuticals vs Reflector BioRecursion OS and Reflector phenotypic screening both list drug discovery; both also serve buyers who need to find drug candidates faster; Reflector Bio's scale not recorded; ships application rather than the same layer.
• Recursion Pharmaceuticals vs LunitLunit SCOPE and Recursion OS both list drug discovery; both also serve buyers who need to find drug candidates faster; Lunit's scale not recorded; ships platform rather than the same layer.
• Recursion Pharmaceuticals vs OwkinBiomarkerPlus and Recursion OS both list drug discovery; Owkin's scale not recorded; ships platform rather than the same layer.
• Recursion Pharmaceuticals vs Google DeepMindAlphaFold Server and Recursion OS both list drug discovery; Google DeepMind is acquired, with no independent scale; ships platform rather than the same layer.
• Recursion Pharmaceuticals vs Tempus AIRecursion OS and Tempus Lens both list drug discovery; larger scale (public); ships agent platform and application rather than the same layer.
• Recursion Pharmaceuticals vs Huawei CloudRecursion OS and EIHealth both list drug discovery; Huawei Cloud's scale not recorded.
• Recursion Pharmaceuticals vs NVIDIARecursion OS and NVIDIA BioNeMo both list drug discovery; larger scale (public).